Sanofi’s Sarclisa gets approved as a first-line option for some patients newly diagnosed with multiple myeloma

Sign up for free to read a limited number of articles each month.

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

Long Q4 Lifts Organigram Revenue

Organigram Reports Fiscal 2023 Results¹ Domestic share growth in several key categories continues to be driven by innovation excellence and industry-leading R&D. Organigram continues to

Read More »